GILD
XNASGILEAD SCIENCES INC
Avg. sentiment
0.30neutral
1 news · 90d
7d trend
——
0 news · vs previous 7d (—)
Breakdown
↑ 0• 1↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
No price data available for this ticker.
Track $GILD sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- BusinessWire5/21/2026, 1:30:00 PMGilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio
Gilead Sciences has completed its acquisition of Tubulis GmbH, a private German clinical-stage biotech specializing in next-generation antibody-drug conjugates (ADCs). The deal adds Tubulis' ADC platform and pipeline assets to Gilead's oncology portfolio, enabling more selective tumor-targeted payload delivery. The acquisition was previously announced, making this a closing confirmation rather than a new deal disclosure.
Sentiment 0.30Relevance 100%